Evidence map›Paper›PMID 36570553›Full record

ArticleJournal of surgical case reports2022

Oesophageal neuroendocrine tumours-case series of a rare malignancy.

Amanda L Nikolic, James Gullifer, Mary Ann Johnson, Michael W Hii

Open access · goldAbstract readCase Reports
In one paragraph

Article in Journal of surgical case reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Amanda L NikolicDepartment of Hepatobiliary and Upper Gastrointestinal Surgery, St Vincent's Hospital Melbourne, Fitzroy 3065, Australia.ORCID https://orcid.org/0000-0003-4650-6907
James GulliferDepartment of Anatomical Pathology, St Vincent's Hospital Melbourne, Fitzroy 3065, Australia.
Mary Ann JohnsonDepartment of Hepatobiliary and Upper Gastrointestinal Surgery, St Vincent's Hospital Melbourne, Fitzroy 3065, Australia.
Michael W HiiDepartment of Hepatobiliary and Upper Gastrointestinal Surgery, St Vincent's Hospital Melbourne, Fitzroy 3065, Australia.
St Vincent's Hospital Melbourne · AUThe University of Melbourne · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Oesophageal neuroendocrine neoplasms (NENs) are rare tumours. Neuroendocrine carcinomas (NECs) are the highest grade of NENs, with aggressive biological behaviour and poor outcomes. No standardized treatment pathways exist for these tumours, with management being individualized based on patient and tumour factors. We present five cases, four men and one women between 63 and 68 years old, who were diagnosed with symptomatic primary oesophageal NECs. Three were diagnosed with localized disease, and two were diagnosed with metastatic disease. Endoscopy, biopsy and staging scan results are outlined. Two patients received neoadjuvant chemotherapy. Three patients with localized disease underwent oesophagectomy. Two of these patients received neoadjuvant chemotherapy. Four patients have succumbed to their disease, with a median survival following a diagnosis of 18 months (5-34 months). This case series highlights the variability of presentation and stage at diagnosis of oesophageal NECs. Multimodal treatment is commonly utilized; however, outcomes are universally poor. Further research is required to determine the optimal treatment regimen for oesophageal NENS.

Indexed as

case seriesneuroendocrine neoplasmoesophageal neoplasm

Identifiers

PMID36570553
PMCPMC9769948
OpenAlexW4312210553

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.